The second day of the 2016 edition of CED’s Tech Venture Conference
highlighted industry wide trends of sharpening consumer focus and opening access to innovation, all with an eye to promoting the region’s increasing economic momentum.
CEO Kim Lebow
kicked off the morning with a dissection of the power of “informed decision makers” in the world of healthcare IT. Lebow unpacked the shift from practice-first mentality that previously guided product development in the healthcare vertical to the rise of the patient-as-consumer, whom her digital, personal medical records product serve.
The new normal in healthcare IT, she notes, places consumers in the driver’s seat, flipping the old B2B sales model.
A similar inversion is underway in the investor courtship process with the passage of Senate Bill 481 (also known as the PACES Act) which legalized crowdfunding in North Carolina. NC Secretary of State Elaine Marshall said at a well-attended workshop led by the NC Department of Commerce that she is thrilled about the way the legislation "balances protection for investors and opportunity for companies” by attracting new money for emerging companies.
The corporate VC panel focused on championing deals and products, sometimes well before those companies are ready for growth-stage funding. Alisyn Malek
, investment manager at GM Ventures
, and Chris Langford
of Lowe’s Ventures explained in a panel moderated by Don Rainey
of Grotech Ventures
that corporate-style VCs are striking agreements without the old standard downsides.
Both said they’ve forsworn first right of refusal clauses that bound corporate portfolio companies to their corporate partners and the danger of “inheriting enemies” as Langford termed the shadow big companies can cast on their investments. They and their fellow corporate investors strive to style themselves more like their independent peers all while bringing innovation to their parent companies.
The morning wrapped up with yet another example of a democratizing technology (3D manufacturing) and a comment on the ongoing political controversy in the state.
CEO, serial entrepreneur and University of North Carolina at Chapel Hill chemistry professor Joe DeSimone
(pictured above), who has raised more than $100 million from the top investors worldwide, shared his plans to open a facility with 300-400 employees on the East Coast. Only HB2 could prevent it from being in NC, he said.
The big picture on Wednesday was crystal clear: there are more ways to get into innovative companies, to fund them and serve customers, and it's all happening right here in the Triangle.